Accuracy of an adrenocorticotropic hormone (ACTH) immunoluminometric assay for differentiating ACTH-dependent from ACTH-independent hyperadrenocorticism in dogs

Journal of Veterinary Internal Medicine

Volumn 23, Issue 4, 2009, Pages 850-855

  Rodriguez Pineiro M I ^a,b   Benchekroun, G ^a   de Fornel Thibaud, P ^a,c   Maurey Guenec, C ^a   Garnier, F ^d   Rosenberg, D ^a  

^a ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c Veterinary Anticancer Center   (France)

^d VETAGRO SUP   (France)

Author keywords

Adrenal gland; Adrenocortical tumors; Adrenocorticotropic hormone; Endocrinology

Indexed keywords

CORTICOTROPIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; DOG; DOG DISEASE; HYPERALDOSTERONISM; LUMINESCENCE; REPRODUCIBILITY; RETROSPECTIVE STUDY;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; DOG DISEASES; DOGS; HYPERALDOSTERONISM; LUMINESCENT MEASUREMENTS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

ANIMALIA; CANIS FAMILIARIS;

EID: 67749090819     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2009.0328.x     Document Type: Article

References (50)

1. Feldman EC, Nelson RW. Hyperadrenocorticism (Cushing's syndrome). In: Feldman EC, Nelson RW, eds. Canine and Feline Endocrinology and Reproduction. St Louis, MO: Saunders; 2004:252-357.
2. Churcher RK. Hepatic carcinoid, hypercortisolism and hypo-kalaemia in a dog. Aust Vet J 1999; 77: 641-645.
3. Galac S, Kooistra HS, Voorhout G, et al. Hyperadrenocorticism in a dog due to ectopic secretion of adrenocorticotropic hormone. Domest Anim Endocrinol 2005; 28: 338-348.
4. Galac S, Kars VJ, Voorhout G, et al. ACTH-independent hyperadrenocorticism due to food-dependent hypercortisolemia in a dog: A case report. Vet J 2008; 177: 141-143.
5. Feldman EC, Blake Tyrell J, Bohannon NV. The synthetic ACTH stimulation test and measurement of endogenous plasma ACTH levels: Useful diagnostic indicators for adrenal disease in dogs. J Am Anim Hosp Assoc 1978; 14: 524-531.
6. Meijer JC, de Bruijne JJ, Rijnberk A, Croughs RJ. Biochemical characterization of pituitary-dependent hyperadrenocorticism in the dog. J Endocrinol 1978; 77: 111-118.
7. Feldman EC. Distinguishing dogs with functioning adrenocortical tumors from dogs with pituitary-dependent hyperadrenocorticism. J Am Vet Med Assoc 1983; 183: 195-200.
8. Kantrowitz BM, Nyland TG, Feldman EC. Adrenal ultra-sonography in the dog. Detection of tumors and hyperplasia in hyperadrenocorticism. Vet Radiol Ultrasound 1986; 27: 91-96.
9. Barthez PY, Nyland TG, Feldman EC. Ultrasonographic evaluation of the adrenal glands in dogs. J Am Vet Med Assoc 1995; 207: 1180-1183.
10. Grooters AM, Biller DS, Theisen SK, Miyabayashi T. Ul-trasonographic characteristics of the adrenal glands in dogs with pituitary-dependent hyperadrenocorticism: Comparison with normal dogs. J Vet Intern Med 1996; 10: 110-115.
11. Feldman EC, Nelson RW, Feldman MS. Use of low- and high-dose dexamethasone tests for distinguishing pituitary-dependent from adrenal tumor hyperadrenocorticism in dogs. J Am Vet Med Assoc 1996; 209: 772-775.
12. Besso JG, Penninck DG, Gliatto JM. Retrospective ultrasonographic evaluation of adrenal lesions in 26 dogs. Vet Radiol Ultrasound 1997; 38: 448-455.
13. Hoerauf A, Reusch CE. Ultrasonographic characteristics of both adrenal glands in 15 dogs with functional adrenocortical tumors. J Am Anim Hosp Assoc 1999; 51: 193-199.
14. Norman EJ, Thompson H, Mooney CT. Dynamic adrenal function testing in eight dogs with hyperadrenocorticism associated with adrenocortical neoplasia. Vet Rec 1999; 144: 551-554.
15. Feldman EC, Bohannon NV, Tyrrell JB. Plasma adrenocorticotropin levels in normal dogs. Am J Vet Res 1977; 38: 1643-1645.
16. Kemppainen RJ, Sartin JL. Evidence for episodic but not circadian activity in plasma concentrations of adrenocorticotrophin, cortisol and thyroxine in dogs. J Endocrinol 1984; 103: 219-226.
17. Hegstad RL, Johnston SD, Pasternak DM. Effects of sample handling on adrenocorticotropin concentration measured in canine plasma, using a commercially available radioimmunoassay kit. Am J Vet Res 1990; 51: 1941-1947.
18. Keller-Wood M. Fast feedback control of canine corticotropin by cortisol. Endocrinology 1990; 126: 1959-1966.
19. Scott-Moncrieff JC, Koshko MA, Brown JA, et al. Validation of a chemiluminescent enzyme immunometric assay for plasma adrenocorticotropic hormone in the dog. Vet Clin Pathol 2003; 32: 180-187.
20. Reusch CE, Feldman EC. Canine hyperadrenocorticism due to adrenocortical neoplasia. Pretreatment evaluation of 41 dogs. J Vet Intern Med 1991; 5: 3-10.
21. Gould SM, Baines EA, Mannion PA, et al. Use of endogenous ACTH concentration and adrenal ultrasonography to distinguish the cause of canine hyperadrenocorticism. J Small Anim Pract 2001; 42: 113-121.
22. Bertolini G, Furlanello T, Drigo M, Caldin M. Computed tomographic adrenal gland quantification in canine adrenocorticotroph hormone-dependent hyperadrenocorticism. Vet Radiol Ultrasound 2008; 49: 449-453.
23. Meijer JC, Lubberink AA, Rijnberk A, Croughs RJ. Adrenocortical function tests in dogs with hyperfunctioning adrenocortical tumours. J Endocrinol 1979; 80: 315-319.
24. Feldman EC. Comparison of ACTH response and dexamethasone suppression as screening tests in canine hyperadrenocorticism. J Am Vet Med Assoc 1983; 182: 506-510.
25. Granger N, de Fornel P, Devauchelle P, et al. Plasma proopiomelanocortin, pro-adrenocorticotropin hormone, and pituitary adenoma size in dogs with Cushing's disease. J Vet Intern Med 2005; 19: 23-28.
26. Ginel PJ, Perez-Rico A, Moreno P, Lucena R. Validation of a commercially available enzyme-linked immunosorbent assay (ELISA) for the determination of cortisol in canine plasma samples. Vet Res Commun 1998; 22: 179-185.
27. Grooters AM, Biller DS, Merryman J. Ultrasonographic parameters of normal canine adrenal glands: Comparison to necropsy findings. Vet Radiol Ultrasound 1995; 36: 126-130.
28. Voorhout G, Stolp R, Lubberink AA, van Waes PF. Computed tomography in the diagnosis of canine hyperadrenocorticism not suppressible by dexamethasone. J Am Vet Med Assoc 1988; 192: 641-646.
29. Reusch CE. Hyperadrenocorticism. In: Ettinger SJ, ed. Text-book of Veterinary Internal Medicine. Diseases of the Dog and Cat. Philadelphia, PA: Saunders; 2005:1592-1612.
30. Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 1998; 19: 647-672.
31. Boscaro M, Barzon L, Fallo F, Sonino N. Cushing's syndrome. Lancet 2001; 357: 783-791.
32. Mack RE, Feldman EC. Comparison of two low-dose dexa-methasone suppression protocols as screening and discrimination tests in dogs with hyperadrenocorticism. J Am Vet Med Assoc 1990; 197: 1603-1606.
33. Zeugswetter F, Hoyer MT, Pagitz M, et al. The desmopressin stimulation test in dogs with Cushing's syndrome. Domest Anim Endocrinol 2008; 34: 254-260.
34. Behrend EN, Kemppainen RJ, Clark TP, et al. Diagnosis of hyperadrenocorticism in dogs: A survey of internists and dermatologists. J Am Vet Med Assoc 2002; 220: 1643-1649.
35. Rijnberk A, der Kinderen PJ, Thijssen JH. Spontaneous hyperadrenocorticism in the dog. J Endocrinol 1968;41: 397-406.
36. Siegel ET, Kelly DF, Berg P. Cushing's syndrome in the dog. J Am Vet Med Assoc 1970; 157: 2081-2090.
37. Ling GV, Stabenfeldt GH, Comer KM, et al. Canine hyperadrenocorticism: Pretreatment clinical and laboratory evaluation of 117 cases. J Am Vet Med Assoc 1979; 174: 1211-1215.
38. Peterson ME. Hyperadrenocorticism. Vet Clin North Am Small Anim Pract 1984; 14: 731-749.
39. Gosling JP. A decade of development in immunoassay methodology. Clin Chem 1990; 36: 1408-1427.
40. Selby C. Interference in immunoassay. Ann Clin Biochem 1999;36(Part 6):704-721.
41. Mueller C, Sieber-Ruckstuhl N, Wenger M, et al. Low-dose dexamethasone test with "inverse" results: A possible new pattern of cortisol response. Vet Rec 2006; 159: 489-491.
42. Ford SL, Feldman EC, Nelson RW. Hyperadrenocorticism caused by bilateral adrenocortical neoplasia in dogs: Four cases (1983-1988). J Am Vet Med Assoc 1993; 202: 789-792.
43. Greco DS, Peterson ME, Davidson AP, et al. Concurrent pituitary and adrenal tumors in dogs with hyperadrenocorticism: 17 cases (1978-1995). J Am Vet Med Assoc 1999; 214: 1349-1353.
44. Thuroczy J, van Sluijs FJ, Kooistra HS, et al. Multiple endocrine neoplasias in a dog: Corticotrophic tumour, bilateral adrenocortical tumours, and pheochromocytoma. Vet Q 1998;20: 56-61.
45. Kiupel M, Mueller PB, Ramos VJ, et al. Multiple endocrine neoplasia in a dog. J Comp Pathol 2000; 123: 210-217.
46. Kemppainen RJ, Clark TP, Peterson ME. Preservative effect of aprotinin on canine plasma immunoreactive adrenocorticotropin concentrations. Domest Anim Endocrinol 1994; 11: 355-362.
47. Castillo VA, Cabrera Blatter MF, Gomez NV, et al. Diurnal ACTH and plasma cortisol variations in healthy dogs and in those with pituitary-dependent Cushing's syndrome before and after treatment with retinoic acid. Res Vet Sci 2009; 86: 223-229.
48. Hanson JM, Kooistra HS, Mol JA, et al. Plasma profiles of adrenocorticotropic hormone, cortisol, alpha-melanocyte-stimulating hormone, and growth hormone in dogs with pituitarydependent hyperadrenocorticism before and after hypophysectomy. J Endocrinol 2006; 190: 601-609.
49. Kooistra HS, Greven SH, Mol JA, Rijnberk A. Pulsatile secretion of alpha-MSH and the differential effects of dexamethasone and haloperidol on the secretion of alpha-MSH and ACTH in dogs. J Endocrinol 1997; 152: 113-121.
50. Orth DN, Peterson ME, Drucker WD. Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Cushing's syndrome: Diurnal rhythm and responses to various stimuli. Endocrinology 1988; 122: 1250-1262.